| Catalyst | Drug/Treatment | Stage | Probability of Approval | Description | Drug Type | Therapeutic Area | Source |
|---|---|---|---|---|---|---|---|
PDUFA 2026 | Phase 3 | -% | FDA review of the new drug application for the treatment of example condition. Read More | Small Molecule | Oncology | ||
PDUFA 2026 | Phase 3 | -% | FDA review of the new drug application for the treatment of example condition. Read More | Small Molecule | Oncology | ||
PDUFA 2026 | Phase 3 | -% | FDA review of the new drug application for the treatment of example condition. Read More | Small Molecule | Oncology |
Recent Updates
Recently added Catalysts
Cronos Group Inc. Common Share$3.02
+0.3 (+11.21%)
0Pipeline Score NOT_PHARMA · Pre-Clinical
Market Cap
1.12 B
EPS
0.01
P/E Ratio
305.5 $
Value Trade
5.26 M
SEC Financials
Q2 2026Dilution Risk
Revenue
53.01 M
R&D Expenses
1.22 M
Total Assets
1.18 B
Total Liabilities
62.41 M
Equity
1.07 B
5.71 %
Week
11.09 %
1 Month
18.87 %
3 Month
19.34 %
6 Month
-63.32 %
5 Year
1,550.6 %
All Time
Cash Data
Cash Position
797.02 M
Monthly Burn
-
Runway
-
Burn Trend
StableSEC Filing
Aug 6, 2026
Overview
Volume
3.44 M
52 Week Range
2.14 - 3.43
% held by Insiders
49.82 %
% held by Institutions
14.53 %
Enterprise Value
341.14 M
Total Shares
373.03 M
Short %
1.87 %
Float Shares
193.68 M
Company Description
locked
Upcoming Catalyst
Catalyst Timeline
Dated clinical, regulatory & corporate events for Cronos Group Inc. Common Share
105Total events
1Upcoming
28Tier-1 (high impact)
2017 – 2026Coverage
Upcoming catalysts 1
TBD
T1Acquisition
Subscribe to view catalyst details
Event history 2
TBD
◆Quarterly UpdateCorporate
Subscribe to view catalyst details
TBD
●Quarterly UpdateCorporate
Subscribe to view catalyst details
Past FDA Catalysts & PDUFA Decisions
| Date | Drug | Catalyst | Stage | Outcome | Reaction | Event Move % | Best Trade % |
|---|---|---|---|---|---|---|---|
— | Example Drug | Phase 3 data readout | Phase 3 | — | – | 0% | 0% |
— | Example Drug | Phase 3 data readout | Phase 3 | — | – | 0% | 0% |
— | Example Drug | Phase 3 data readout | Phase 3 | — | – | 0% | 0% |
Drug Pipeline Intelligence
0
Pipeline Score -
Pipeline ValueValuation Signal
0
Drugs Scored—
rNPV / MCap Top 2%
Micro Cap (rank 906 of 923)
Percentile RankClinical Trial Results
| Drug Name | Indications | Phase | Date | Trial Results Summary | Title | Source |
|---|---|---|---|---|---|---|
Example Drug | Example indication for clinical evaluation | Phase 3 | 2025-12-01 | The study met its primary endpoint demonstrating statistically significant improvement. Read More | Phase 3 Study Results Announcement | |
Example Drug | Example indication for clinical evaluation | Phase 3 | 2025-12-01 | The study met its primary endpoint demonstrating statistically significant improvement. Read More | Phase 3 Study Results Announcement | |
Example Drug | Example indication for clinical evaluation | Phase 3 | 2025-12-01 | The study met its primary endpoint demonstrating statistically significant improvement. Read More | Phase 3 Study Results Announcement |
Inside Trades
YEARLY INSIDER TRANSACTIONS
Sector Avg.
INSIDERS
SOLDINSIDERS
BOUGHT
SOLDINSIDERS
BOUGHT
POSITIVE SENTIMENT Based on 22 Insiders Transactions
Hedge Funds
Shares Held
HEDGE FUNDS
SOLDHEDGE FUNDS
BOUGHT
SOLDHEDGE FUNDS
BOUGHT
POSITIVE SENTIMENT Based on 27 hedge funds in the last quarter
18 buying (3 new)·9 selling (1 exited)·2 unchanged
Hedge Funds invested in CRON
| HedgeFund Name ( 3 ) | % of Portfolio | Current MV - | Shares Owned - | Activity Avg Price $0 |
|---|---|---|---|---|
Example Capital Management | 2.5 % | 15.00 M | 250.00 K | |
Example Capital Management | 2.5 % | 15.00 M | 250.00 K | |
Example Capital Management | 2.5 % | 15.00 M | 250.00 K |
CRON Institutional Ownership Trends
Current Insider %
5.20%
—+0.00%
Current Institutional %
62.40%
—+0.00%
Total Ownership
67.60%
Insider + Institutional
Data Points
1
1 Ticker(s)
Option Chain Statistics
| Expiration | Volume | Open Interest | Implied Volatility Calls | Implied Volatility Puts | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Calls | Puts | Put-Call Ratio | Calls | Puts | Put-Call Ratio | IV | OiWaIv | VWaIv | IV | OiWaIv | VWaIv | |
| 2026-09-18 | 0.00 | 0 | - | - | - | - | - | - | ||||
| 2026-09-18 | 0.00 | 0 | - | - | - | - | - | - | ||||
| 2026-09-18 | 0.00 | 0 | - | - | - | - | - | - | ||||
Option Chain
| Calls | Strike | Puts | ||||
|---|---|---|---|---|---|---|
| Last Price | Volume | Open Interest | Last Price | Volume | Open Interest | |
| No data available | ||||||
Open interest
Today's Open Interest
1.00 M
Put-Call Ratio
1.1
Put Open Interest
480.00 K
Call Open Interest
520.00 K
Open Interest Avg (30-day)
900,000
Today vs Open Interest Avg (30-day)
11.11%
Option Volume
Today's Volume
750.00 K
Put-Call Ratio
0.95
Put Volume
360.00 K
Call Volume
390.00 K
Volume Avg (30-day)
800,000
Today vs Volume Avg (30-day)
-6.25%
Company News
CRON▲ +11.2%today
Cronos Group Reports 2026 Second Quarter Results
Cronos Group reported impressive financial results for Q2 2026, with a 51% year-over-year increase in net revenue, driven by strong sales in Canada and international markets. The company achieved record gross profit and Adjusted EBITDA, highlighting the success of its Spinach® and PEACE NATURALS® brands. However, Cronos faces challenges from ongoing investigations in Israel and rising operating expenses.
Read more →CRONCronos’ SOURZ by Spinach® Expands its Lineup of Edibles
Cronos Group Inc. is expanding its SOURZ by Spinach® Fully Blasted multipacks to cater to the rising consumer demand for edibles during summer. The new lineup includes popular flavors and a limited-time offer. The brand continues to lead the Canadian edible market with significant market share, reflecting its strong consumer loyalty.
Read more →CRONCronos Group Inc. to Hold 2026 Second Quarter Earnings Conference Call on August 6, 2026
Cronos Group Inc. will hold its 2026 second quarter earnings conference call on August 6, 2026, at 8:30 a.m. ET. Senior management will discuss financial results and answer questions from investors. Participants are encouraged to register online and join the call early. The call will also be available for replay on the company's website.
Read more →CRONCronos Announces Appointment of ATB Cormark as its Broker for Share Repurchases in Canada
Cronos Group Inc. has appointed ATB Capital Markets Corp. as its broker for share repurchases, replacing Virtu Canada Corp. This decision is part of Cronos' ongoing share repurchase program. The company aims to enhance its market presence while focusing on innovation and consumer experience in the cannabis sector.
Read more →CRONCronos Group Inc. Announces Results of 2026 Annual Meeting of Shareholders
Cronos Group Inc. held its Annual Meeting of Shareholders on June 18, 2026, where 72.24% of shareholders participated. All nominated directors were elected with over 93.6% approval. An advisory resolution on executive compensation received 99.09% support, and Davidson & Company LLP was appointed as the independent auditor for fiscal year 2026.
Read more →CRONCronos Announces Extension of Share Repurchase Program to the Toronto Stock Exchange
Cronos Group Inc. has announced an extension of its share repurchase program, now accepted by the Toronto Stock Exchange. The program allows for the repurchase of up to $50 million in common shares, with purchases expected to begin on June 19, 2026. Additionally, Cronos received an exemption from the Ontario Securities Commission to facilitate repurchases on U.S. markets.
Read more →CRON▲ +8.3%on this news
Cronos Group Reports 2026 First Quarter Results
Cronos Group reported a remarkable 40% increase in net revenue for Q1 2026, reaching $45.2 million. The company achieved record gross profit and maintained its leading market position in Canada, particularly with its Spinach brand in the vape category. Internationally, Cronos saw significant growth, especially in Israel. However, the company faces challenges with rising operating expenses and the pending acquisition of CanAdelaar, which requires regulatory approval.
Read more →CRONCronos Expands Pre-Roll Portfolio with Spinach STIX®
Cronos Group Inc. has announced the expansion of its Spinach STIX pre-rolls into more provinces in Canada. This new cylindrical-style pre-roll is designed to cater to the growing consumer interest in portable and consistent smoking options. The pre-roll category is significant in the Canadian market, contributing to over 33% of retail sales. Cronos aims to enhance its product lineup to meet evolving consumer preferences.
Read more →CRONCronos Group Inc. to Hold Virtual 2026 Annual Meeting of Shareholders
Cronos Group Inc. will host its 2026 Annual Meeting of Shareholders on June 18, 2026, at 11:00 a.m. ET in a virtual-only format. This allows registered shareholders and proxyholders to participate online, ask questions, and vote regardless of location. Detailed instructions and a proxy statement are available on the company's website.
Read more →CRONCronos Group Inc. to Hold 2026 First Quarter Earnings Conference Call on May 11, 2026
Cronos Group Inc. will host its 2026 first quarter earnings conference call on May 11, 2026, at 8:30 a.m. ET. The senior management team will present the company's financial results and answer questions from investors. Participants are encouraged to register in advance and can access a replay of the call on the company's website.
Read more →CRONCronos Group Inc. to Speak at the 38th Annual ROTH Conference
Cronos Group Inc. announced that its Chairman, President, and CEO, Mike Gorenstein, will speak at the 38th Annual ROTH Conference on March 23, 2026. The event will be accessible via a live webcast on the company's investor relations website. Cronos is recognized for its commitment to cannabis research and developing a diverse brand portfolio.
Read more →CRONCronos Group Reports 2025 Fourth Quarter and Full-Year Results
Cronos Group reported record net revenue of $44.5 million for Q4 2025, marking a 47% year-over-year increase, and $146.6 million for the full year, a 25% increase. The company attributes this growth to strong demand for its brands and the expansion of Cronos GrowCo. However, it faced a net loss in Q4 2025, contrasting with a profit in the same quarter of 2024, primarily due to increased operating expenses and supply challenges in Canada. The pending acquisition of CanAdelaar is expected to enhance its market presence in Europe.
Read more →CRONCronos Launches New All-in-One Vape, Spinach PUFFERZ™
Cronos Group Inc. has launched its new all-in-one vape, Spinach PUFFERZ™, designed for cannabis consumers. This innovative device features high-quality cannabis infused with liquid diamonds and offers a range of user-friendly features. Available initially in Alberta, British Columbia, and Ontario, it will be rolled out nationally by April 2026. The launch reflects Cronos' commitment to product quality and brand loyalty.
Read more →CRONCronos Group Inc. to Hold 2025 Fourth Quarter and Full-Year Earnings Conference Call on February 26, 2026
Cronos Group Inc. will hold its fourth quarter and full-year earnings conference call on February 26, 2026, at 8:30 a.m. ET. The senior management team will discuss financial results and answer questions from investors. Participants can register online and are encouraged to join early. The call will be archived for later access.
Read more →CRON▲ +8.9%on this news· ran to +32% by day 3
Document Cronos to enter the Netherlands with acquisition of Europe's largest adult-use cannabis company Cronos to acquire CanAdelaar for up-front cash consideration of US$67.0M 1 plus cash earnout of 0.5x normalized EBI
Cronos Group Inc. is set to acquire CanAdelaar B.V., the largest adult-use cannabis company in the Netherlands, for an upfront cash payment of $67 million. This acquisition positions Cronos as the market leader in the Netherlands' cannabis industry, which is regulated under the Wietexperiment pilot program. The transaction includes additional contingent payments based on CanAdelaar's future earnings, further supporting Cronos' expansion strategy in Europe. The acquisition is expected to finalize in early 2026, pending regulatory approvals.
Read more →CRONCronos Group Reports 2025 Third Quarter Results
Cronos Group reported strong financial results for Q3 2025, achieving record levels in net revenue, gross profit, and adjusted EBITDA. The company's performance was bolstered by continued success in Israel, where its PEACE NATURALS brand leads the market. Despite facing temporary supply constraints in Canada, Cronos maintains a robust balance sheet with significant cash reserves, positioning it well for future growth.
Read more →CRONCronos Brings Back Popular, Limited-Edition Spinach® Green Apple-Flavored Products for the Fall Season
Cronos Group Inc. has reintroduced its limited-edition Caramel Green Apple gummies for the fall season, following last year's success. The company is also expanding its offerings with two new seasonal products. These items are now available across Canada, aiming to enhance consumer engagement during the autumn months.
Read more →CRONCronos Group Inc. to Hold 2025 Third Quarter Earnings Conference Call on November 6, 2025
Cronos Group Inc. will host its third quarter earnings conference call on November 6, 2025, at 8:30 a.m. ET. The call will feature discussions on the company's financial results, followed by a Q&A session with senior management. Participants are encouraged to register in advance for the call.
Read more →CRONCronos launches SOURZ by Spinach® Fully Blasted Multipacks
Cronos Group Inc. has launched SOURZ by Spinach® Fully Blasted Multipacks, featuring liquid diamond-infused gummies in popular flavors. This new format aims to provide consumers with greater choice and convenience. The product is now available in various Canadian provinces, reinforcing SOURZ's position as a leading cannabis edible brand.
Read more →CRON▲ +8.1%on this news· ran to +22% by day 3
Cronos Group Reports 2025 Second Quarter Results
Cronos Group reported significantly improved second quarter results for 2025, with net revenue of $33.5 million, up 21% from last year, primarily due to increased sales in Israel and other international markets. The company's strong performance in the medical cannabis sector in Israel contributed to these results, alongside the successful consolidation of Cronos GrowCo. However, a notable net loss of $38.5 million highlights challenges like currency fluctuations and supply constraints in Canada. Despite these issues, Cronos maintains a strong financial position with substantial cash reserves to support its growth strategy.
Read more →CRONCronos Grows its International Footprint in Switzerland
Cronos Group Inc. is expanding its PEACE NATURALS medical cannabis brand into Switzerland through a partnership with Dascoli Pharma AG. This collaboration will allow Cronos to leverage Dascoli's established distribution network to better serve Swiss patients. The move is part of Cronos's broader strategy to grow its international presence in emerging medical cannabis markets.
Read more →CRONCronos Group Inc. Announces Results of 2025 Annual Meeting of Shareholders
Cronos Group Inc. held its Annual Meeting of Shareholders on June 20, 2025, with 71.87% of shares voted. All nominated directors were elected with over 92.3% approval. Shareholders also supported an advisory resolution on executive compensation with 94.13% approval and appointed Davidson & Company LLP as the independent auditor for 2025.
Read more →CRONCronos Group Inc. to Speak at the TD Cowen 9th Annual Future of the Consumer Conference
Cronos Group Inc. will be represented by CEO Mike Gorenstein at the TD Cowen 9th Annual Future of the Consumer Conference on June 4, 2025. The event will be accessible via a live webcast on the company's investor relations website. Cronos is committed to advancing cannabis research and building a strong brand portfolio.
Read more →CRON▲ +8.1%on this news
Cronos Group Reports 2025 First Quarter Results
Cronos Group Inc. reported strong Q1 2025 results, with net revenue increasing by 28% from the previous year, driven largely by sales of cannabis flower and extracts. The company's PEACE NATURALS® brand continues to dominate the Israeli market, while their Spinach® brand ranks highly in Canada. Despite challenges from supply limitations affecting product availability, Cronos is focused on expanding its operations and has authorized a $50 million share repurchase plan. These efforts aim to support growth amid increasing demand in the global cannabis market.
Read more →CRONCronos Group Inc. Announces Results of 2024 Annual Meeting of Shareholders
Cronos Group Inc. held its Annual Meeting of Shareholders on June 20, 2024, where 71.75% of common shares were represented. All nominated directors were successfully elected with significant majority votes exceeding 93.4%. Shareholders also approved an advisory resolution on executive compensation with 96.19% approval. The meeting was adjourned to allow for the identification of a successor independent auditor, with a reconvened meeting planned to vote on this appointment.
Read more →CRON▼ -8%on this news
Cronos Group Reports 2023 Fourth Quarter and Full-Year Results
Cronos Group reported its financial results for the fourth quarter and full year of 2023, highlighting an increase in net revenue and cash reserves. The company's consolidated net revenue rose by 9% in Q4 compared to the previous year, driven mainly by higher sales in Canada and entry into international markets like Australia and Germany. Despite these gains, the company faced challenges such as lower sales in Israel due to regional conflicts and pricing pressures impacting overall profitability. The launch of the Lord Jones® brand in Canada has shown promise, supporting the company's strategic growth objectives for 2024.
Read more →CRON▼ -5%on this news
Cronos Enters Australian Cannabis Market
Cronos Group Inc. is expanding its footprint into the Australian cannabis market by initiating shipments of cannabis flower to Vitura Health Limited. This marks a significant milestone for the company as it aims to enter and expand within international markets. With growing approvals for medical cannabis patients in Australia, Cronos intends to leverage its experience from markets like Canada and Israel to enhance Vitura's market share. The partnership focuses on providing high-quality cannabis products while navigating competition in this emerging market space.
Read more →CRONDocument Cronos Group Announces Streamlined Operating Structure to Improve Cash Flow Plans to Exit Existing U.S. hemp-derived CBD Operations Intends to Launch Lord Jones Brand in the Canadian Adult-use Market in Q4 2023
Cronos Group announces a streamlined operating structure aimed at enhancing cash flow by exiting its U.S. hemp-derived CBD operations by the end of Q2 2023. The company plans to consolidate its financial reporting and increase its cost savings target to $20-$25 million. Additionally, Cronos intends to launch its Lord Jones brand in Canada in Q4 2023. The strategic move is designed to position Cronos favorably for future opportunities in the U.S. THC market as regulatory conditions evolve.
Read more →CRON▼ -6.5%on this news
Cronos Group Reports 2023 First Quarter Results Industry-leading balance sheet with $836 million in cash and short-term investments Targeting positive cash flow in 2024 Net revenue in Canada increased 6% in Q1 2023 compa
Cronos Group reported a decrease in consolidated net revenue for Q1 2023, amounting to $20.1 million, a 20% decline from the previous year. While net income loss improved compared to Q1 2022, challenges such as lower cannabis flower sales and increased pricing pressures affected overall performance across its segments. The company holds a robust balance sheet with $836 million in cash and short-term investments and aims for positive cash flow in 2024. Despite challenges in the international markets, particularly in Israel, Cronos remains optimistic about future regulatory changes and product offerings.
Read more →CRONFinancial Results (in thousands of USD) Three months ended December 31, Change Year ended December 31, Change 2022 2021 $ % 2022 2021 $ % Net revenue United States $ 854 $ 3,106 $ (2,252) (73) % $ 5,155 $ 9,874 $ (4,719)
Cronos Group Inc. reported its 2022 fourth quarter and full-year financial results, highlighting a 23% increase in consolidated net revenue compared to 2021. Despite a significant drop in U.S. sales, the company observed strong growth in Israel, where net revenue soared by 128%. The success of the Spinach brand, which became the top edible brand in Canada, marks a notable achievement for the company. Operational cost-saving measures led to a $28.7 million reduction in expenses, which is expected to continue into 2023.
Read more →CRON▼ -9.4%on this news
Financial Results (in thousands of USD) Three months ended September 30, Change Nine months ended September 30, Change 2022 2021 $ % 2022 2021 $ % Net revenue United States $ 514 $ 2,100 $ (1,586) (76) % $ 4,301 $ 6,768
Cronos Group Reports 2022 Third Quarter Results Reported consolidated net revenue increased 3% year-over-year to $20.9 million; on a constant currency basis, consolidated net revenue increased 7% year-over-year to $21.8 million Reported net revenue in Israel increased 88% year-ov
Read more →CRONCronos Group Announces Strategic Investment in PharmaCann, a Leading U.S. Cannabis Company Investment is Expected to Position Cronos Group to Benefit from Rapid Growth in the U.S. Cannabis Market PharmaCann is Well Posit
Cronos Group Announces Strategic Investment in PharmaCann, a Leading U.S. Cannabis Company Investment is Expected to Position Cronos Group to Benefit from Rapid Growth in the U.S. Cannabis Market PharmaCann is Well Positioned in Limited License States Across the Midwest and No
Read more →CRONCronos Group and Ginkgo Bioworks Amend Agreement to Accelerate Commercialization of Cultured Cannabinoids and Cronos Group Begins Commercial Production of CBG BOSTON and TORONTO
Cronos Group and Ginkgo Bioworks Amend Agreement to Accelerate Commercialization of Cultured Cannabinoids and Cronos Group Begins Commercial Production of CBG BOSTON and TORONTO - June 4, 2021 - Cronos Group Inc. (NASDAQ CRON) (TSX CRON) ("Cronos Group"), an innovative global ca
Read more →CRONCronos Group Announces Expanded Leadership Structure to Drive Next Phase of Growth 30-Year CPG Executive Kurt Schmidt Joins Cronos as Chief Executive Officer and Mike Gorenstein Named Executive Chairman TORONTO
Cronos Group Announces Expanded Leadership Structure to Drive Next Phase of Growth 30-Year CPG Executive Kurt Schmidt Joins Cronos as Chief Executive Officer and Mike Gorenstein Named Executive Chairman TORONTO, September 9, 2020 - Cronos Group Inc. (NASDAQ CRON) (TSX CRON) ("C
Read more →CRONNOTICE TO READER As of
As of June 30, 2019, Cronos Group Inc. (the "Company") determined that it no longer qualified as a "foreign private issuer" as such term is defined in Rule 405 under the Securities Act of 1933, which means that the Company, as of January 1, 2020, has been required to comply with
Read more →CRONCronos Group Inc.
Cronos Group Inc. ("Cronos Group" or the "Company") has restated its unaudited condensed interim consolidated financial statements for the three months ended March 31, 2019, the six months ended June 30, 2019, and the three and nine months ended September 30, 2019, which were pre
Read more →CRONAmended and Restated Condensed Interim Unaudited Consolidated Financial Statements
Amended and Restated Condensed Interim Unaudited Consolidated Financial Statements For the Three Months Ended March 31, 2019 and March 31, 2018 (In thousands of Canadian dollars) Cronos Group Inc. ("Cronos Group" or the "Company") has restated its unaudited condensed interim c
Read more →CRONCRONOS GROUP INC. Unaudited Condensed Interim Consolidated Financial Statements For the Three and Nine Months Ended
CRONOS GROUP INC. Unaudited Condensed Interim Consolidated Financial Statements For the Three and Nine Months Ended September 30, 2019 and September 30, 2018 (in thousands of Canadian dollars) Cronos Group Inc. Unaudited Condensed Interim Consolidated Financial Statements For th
Read more →CRONForm 51-102F3 Material Change Report 1. Name and Address of Company Cronos Group Inc. 720 King Street West, Suite 320 Toronto, Ontario M5V 2T3 2. Date of Material Change
Material Change Report Street West, Suite 320 The news release with respect to the material change referred to in this report was disseminated on September 5, 2019. On September 5, 2019, Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) ( Cronos Group ) announced the closing of its
Read more →CRONCRONOS GROUP INC. Unaudited Condensed Interim Consolidated Financial Statements For the Three and Six Months Ended
CRONOS GROUP INC. Unaudited Condensed Interim Consolidated Financial Statements For the Three and Six Months Ended June 30, 2019 and June 30, 2018 (in thousands of Canadian dollars) Cronos Group Inc. Unaudited Condensed Interim Consolidated Financial Statements For the three and
Read more →CRONEXECUTION VERSION MEMBERSHIP INTEREST PURCHASE AGREEMENT by and among CRONOS GROUP INC., REDWOOD HOLDING GROUP, LLC and, solely for purposes of Article 4, Section 6.6, Section 6.7(a), Section 7.2(a)(ii), Section 7.2(c)(i
MEMBERSHIP INTEREST PURCHASE AGREEMENT REDWOOD HOLDING GROUP, LLC solely for purposes of Article 4, Section 6.6, Section 6.7(a), Section 7.2(a)(ii), Section 7.2(c)(ii), Section 9.2, Article 10 and Exhibit A, the KEY PERSONS (as hereinafter defined) Dated as of August 1, 201
Read more →CRONCRONOS GROUP INC. (the Corporation ) Annual Meeting of Shareholders Held on
Annual Meeting of Shareholders Held on June 19, 2019 REPORT OF VOTING RESULTS National Instrument 51-102 Continuous Disclosure Obligations Business Outcome Results of Ballot or Proxy as Applicable FOR: WITHHELD OR AGAINST 1. Election of Directors The elect
Read more →CRONNOTICE OF MEETING AND MANAGEMENT INFORMATION CIRCULAR FOR THE ANNUAL MEETING OF SHAREHOLDERS TO BE HELD ON JUNE 19, 2019 DATED AS OF MAY 8, 2019 CRONOS GROUP INC. NOTICE OF ANNUAL MEETING OF SHAREHOLDERS NOTICE IS HEREBY
INFORMATION CIRCULAR ANNUAL MEETING OF SHAREHOLDERS DATED AS OF MAY 8, 2019 NOTICE OF ANNUAL MEETING OF SHAREHOLDERS NOTICE IS HEREBY GIVEN that the annual meeting (the Meeting ) of the holders (the Shareholders ) of common shares ( Shares ) of Cronos Group Inc. (the Company
Read more →CRONCRONOS GROUP INC. Unaudited Condensed Interim Consolidated Financial Statements For the Three Months Ended
CRONOS GROUP INC. Unaudited Condensed Interim Consolidated Financial Statements For the Three Months Ended March 31, 2019 and March 31, 2018 (in thousands of Canadian dollars) Cronos Group Inc. Unaudited Condensed Interim Consolidated Financial Statements For the three months en
Read more →CRONEXECUTION VERSION INVESTOR RIGHTS AGREEMENT by and between CRONOS GROUP INC. and ALTRIA GROUP, INC. Dated as of
Page ARTICLE 1 DEFINITIONS AND TERMS 2 Section 1.1 Certain Defined Terms 2 Section 1.2 Other Terms 12 Section 1.3 Interpretation and Construction 12 ARTICLE 2 CORPORATE GOVERNANCE 13 Section 2.1 Board Representation 13 Section 2.2 Alt
Read more →CRONCRONOS GROUP INC. Report of Voting Results Special Meeting of Shareholders held on Thursday
Report of Voting Results Special Meeting of Shareholders held on Thursday, February 21, 2019 accordance with Section 11.3 of National Instrument 51-102, this is a report on the matters put to a vote at the special meeting of holders (the Shareholders ) of common shares ( Shar
Read more →CRONCronos Group Inc. Announces Closing of $65 Million Credit Facility TORONTO
Cronos Group Inc. Announces Closing of $65 Million Credit Facility TORONTO, Jan. 23, 2019 /CNW/ - Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) ("Cronos Group" or the "Company") today announced that it has entered into a credit agreement (the "Credit Agreement") with Canadian
Read more →CRONThis document is important and requires your immediate attention. If you are in any doubt as to how to deal with it, you should consult with your investment dealer, broker, lawyer or other professional advisor. This docu
This document is important and requires your immediate attention. If you are in any doubt as to how to deal with it, you should consult with your investment dealer, broker, lawyer or other professional advisor. This document does not constitute an offer or a solicitation to any
Read more →CRONEXECUTION VERSION SUBSCRIPTION AGREEMENT by and among CRONOS GROUP INC., ALTRIA SUMMIT LLC and, solely for the purposes specified herein, ALTRIA GROUP, INC. Dated as of
and, solely for the purposes specified herein, Page ARTICLE 1 DEFINITIONS AND TERMS 1 Section 1.1 Definitions 1 Section 1.2 Other Terms 16 Section 1.3 Interpretation and Construction 16 ARTICLE 2 SUBSCRIPTION, ISSUANCE AND SALE; CLOSING 18 Section 2.1 Sub
Read more →CRONCronos Group Inc. Announces C$2.4 Billion Strategic Investment from Altria Group, Inc. Provides Cronos Group with Additional Capital and Complementary Expertise to Accelerate Its Expansion and Innovation in the Rapidly G
Cronos Group Inc. Announces C$2.4 Billion Strategic Investment from Altria Group, Inc. Provides Cronos Group with Additional Capital and Complementary Expertise to Accelerate Its Expansion and Innovation in the Rapidly Growing Global Cannabis Industry TORONTO, Dec. 7, 2018 /
Read more →CRONCronos Group Confirms Discussions Regarding Potential Investment by Altria Group TORONTO
Cronos Group Confirms Discussions Regarding Potential Investment by Altria Group TORONTO, Dec. 3, 2018 /CNW/ - Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) ("Cronos Group" or the "Company") today confirmed that it is engaged in discussions concerning a potential investment by
Read more →CRONCronos Group Inc. Announces Third Quarter 2018 Results Increased Revenues 186% and Kilograms Sold 213% Year-over-Year Licensed and Commenced Cultivation in Building 4 Announced Landmark Partnership with Ginkgo Bioworks t
Cronos Group Inc. Announces Third Quarter Increased Revenues 186% and Kilograms Sold 213% Year-over-Year Licensed and Commenced Cultivation in Building 4 Announced Landmark Partnership with Ginkgo Bioworks to Produce Cultured Cannabinoids Recreational Brand Spinach Create
Read more →CRONCronos Group Inc. to Hold Third Quarter 2018 Earnings Conference Call TORONTO
Cronos Group Inc. to Hold Third Quarter 2018 Earnings Conference Call TORONTO, Oct. 19, 2018 /CNW/ - Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) ("Cronos Group" or the "Company"), a geographically diversified and vertically integrated cannabis group, will announce its financ
Read more →CRONCanada Makes History and Cronos Group Inc. Looks Forward with Enthusiasm TORONTO
Canada Makes History and Cronos Group Inc. Looks Forward with Enthusiasm TORONTO, Oct. 17, 2018 /CNW/ - Today, Canada became the first G7 country and the second country in the world to legalize cannabis sales for adult recreational use. Founded to build industry leading compa
Read more →CRONCronos Group Inc. Partners with Technion Research & Development Foundation for Cannabinoid-Based Skin Care Treatments TORONTO
Cronos Group Inc. Partners with Technion Research & Development Foundation for Cannabinoid-Based Skin Care Treatments TORONTO, Oct. 15, 2018 /CNW/ - Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) ("Cronos Group" or the "Company"), announced today that it has entered into a spon
Read more →CRONCronos Group Inc. Launches New Recreational Brand Spinach TORONTO
Cronos Group Inc. Launches New Recreational TORONTO, Sept. 13, 2018 /CNW/ - Today, Cronos Group Inc. ("Cronos Group" or the "Company") is pleased to announce the launch of its second cannabis brand for the domestic recreational market, Spinach . On October 17, 2018, Canada is
Read more →CRONCronos Group and Ginkgo Bioworks Announce a Landmark Partnership to Produce Cultured Cannabinoids Leading Companies from Emerging Industries Join Forces to Efficiently Produce High-Purity Cannabinoids at Scale Boston, Ma
Cronos Group and Ginkgo Bioworks Announce a Landmark Partnership to Produce Cultured Cannabinoids Leading Companies from Emerging Industries Join Forces to Efficiently Produce High-Purity Cannabinoids at Scale Boston, Mass. and Toronto, Ont. September 4, 2018 /CNW/ Today, Crono
Read more →CRONCronos Group Inc. Unveils Platform in
Cronos Group Inc. Unveils Platform in TORONTO, Aug. 29, 2018 /CNW/ - Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) ("Cronos Group" or the "Company"), is pleased to announce that it has entered into a joint venture agreement with an affiliate of Agroidea SAS ("AGI"), Colombia's
Read more →CRONCronos Group Inc. Announces Provincial Supply Agreements TORONTO
Cronos Group Inc. Announces Provincial TORONTO, Aug. 21, 2018 /CNW/ - Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) ("Cronos Group" or the "Company"), a geographically diversified and vertically integrated cannabis group, is proud to announce its initial supply agreements for r
Read more →CRONCronos Group Inc. Announces Second Quarter 2018 Results Increased Sales 428% Year-over-Year Signed 5 Year Exclusive Distribution Agreement for Poland Launched Premium Recreational Brand COVE Added 70,000 KG of Additional
Cronos Group Inc. Announces Second Quarter Increased Sales 428% Signed 5 Year Exclusive Distribution Agreement for Poland Launched Premium Recreational Added 70,000 KG of Additional Capacity through Cronos GrowCo JV Signed 5 Year Take-or-Pay Supply Agreement for 100,000 K
Read more →CRONCura Goes International with Cronos Group Inc. TORONTO
Cura Goes International with Cronos Group TORONTO, Aug. 9, 2018 /CNW/ - Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) ("Cronos Group" or the "Company"), is pleased to announce that it has entered into a supply agreement with one of the largest cannabis companies in the world by
Read more →CRONCronos Group Inc. Announces Capacity Expansion with Premier Greenhouse Expert TORONTO
Cronos Group Inc. Announces Capacity Expansion with Premier Greenhouse Expert TORONTO, July 18, 2018 /CNW/ - Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) ("Cronos Group" or the "Company"), is pleased to announce that it has entered into a joint venture partnership with a grou
Read more →CRONCronos Group Inc. to Hold Second Quarter 2018 Earnings Conference Call TORONTO
Cronos Group Inc. to Hold Second Quarter 2018 Earnings Conference Call TORONTO, July 17, 2018 /CNW/ - Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) ("Cronos Group" or the "Company"), a geographically diversified and vertically integrated cannabis group, will announce its finan
Read more →CRONCRONOS GROUP INC. (the Corporation ) Report of Voting Results Annual and Special Meeting of Shareholders held on Thursday
Report of Voting Results Annual and Special Meeting of Shareholders held on Thursday, June 28, 2018 accordance with Section 11.3 of National Instrument 51-102, this is a report on the matters put to a vote at the Corporation s Annual and Special Meeting of Shareholders held on
Read more →CRONCronos Group Inc. Announces Results of Vote for Election of Directors TORONTO
Cronos Group Inc. Announces Results of Vote for Election TORONTO, June 28, 2018 /CNW/ - Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) ("Cronos Group" or the "Company") reports that at its Annual and Special Meeting of Shareholders on June 28, 2018 there were 658 shareholders vo
Read more →CRONCronos Group Inc. Announces Exclusive Distribution Agreement with Delfarma in Poland TORONTO
Cronos Group Inc. Announces Exclusive Distribution Agreement with Delfarma in Poland TORONTO, June 25, 2018 /CNW/ - Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) ("Cronos Group" or the "Company"), is pleased to announce that it has entered into a strategic distribution partner
Read more →CRONCronos Australia is Granted Manufacturing License TORONTO
Cronos Australia is Granted Manufacturing TORONTO, June 19, 2018 /CNW/ - Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) ("Cronos Group" or the "Company"), is pleased to announce that Cronos Australia Pty Ltd. ("Cronos Australia") has been granted a medicinal cannabis Manufacture
Read more →CRONCronos Group Inc. Sets Date for 2018 Annual and Special Meeting of Shareholders TORONTO
Cronos Group Inc. Sets Date for 2018 Annual and Special Meeting of Shareholders TORONTO, June 8, 2018 /CNW/ - Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) ("Cronos Group" or the "Company"), a geographically diversified and vertically integrated cannabis group, will hold its 2
Read more →CRONNOTICE OF MEETING AND MANAGEMENT INFORMATION CIRCULAR FOR THE ANNUAL AND SPECIAL MEETING OF SHAREHOLDERS TO BE HELD ON JUNE 28, 2018 DATED AS OF MAY 28, 2018 A-1 CRONOS GROUP INC. NOTICE OF ANNUAL AND SPECIAL MEETING OF
INFORMATION CIRCULAR ANNUAL AND SPECIAL MEETING OF SHAREHOLDERS DATED AS OF MAY 28, 2018 NOTICE OF ANNUAL AND SPECIAL MEETING OF SHAREHOLDERS NOTICE IS HEREBY GIVEN that the annual and special meeting (the Meeting ) of the holders (the Shareholders ) of common shares ( Share
Read more →CRONCronos Group Inc. To Up List and Begin Trading on Toronto Stock Exchange TORONTO
Cronos Group Inc. To Up List and Begin Trading on Toronto TORONTO, May 22, 2018 /CNW/ - Cronos Group Inc. (NASDAQ, TSX-V: CRON) ("Cronos Group" or the "Company"), is pleased to announce that trading of its common shares in Canada will be elevated from the TSX Venture Exchange
Read more →CRONCronos Group Inc. Appoints Lead Director, Engages Investor Relations Agency and Grants Options TORONTO
Cronos Group Inc. Appoints Lead Director, Engages Investor Relations Agency and Grants Options TORONTO, May 18, 2018 /CNW/ - Cronos Group Inc. (NASDAQ, TSX-V: CRON) ("Cronos Group" or the "Company"), a geographically diversified and vertically integrated cannabis group, annou
Read more →CRONChange of Auditor Reporting Package NOTICE OF CHANGE OF AUDITOR Pursuant to National Instrument 51-102 (Part 4.11) TO: MNP LLP AND TO: KPMG LLP AND TO: British Columbia Securities Commission Alberta Securities Commission
Change of Auditor Reporting Package NOTICE OF CHANGE OF AUDITOR Pursuant to National Instrument 51-102 (Part 4.11) TO: MNP LLP AND TO: KPMG LLP AND TO: British Columbia Securities Commission Alberta Securities Commission Financial and Consumer Affairs Authority of Saska
Read more →CRONCronos Group Inc. Announces First Quarter 2018 Results Q1 2018 total sales of $2.9 million, up 473% year over year Cannabis oil sales represent 29% of domestic medical patient revenue in Q1 2018 TORONTO
Cronos Group Inc. Announces First Quarter 2018 Results Q1 2018 total sales of $2.9 million, up 473% year over year Cannabis oil sales represent 29% of domestic medical patient revenue in Q1 2018 TORONTO, May 15, 2018 /CNW/ - Cronos Group Inc. (NASDAQ, TSX-V: CRON) ("Cronos
Read more →CRONCRONOS GROUP INC. UNAUDITED CONDENSED INTERIM CONSOLIDATED FINANCIAL STATEMENTS For the Three Month Periods Ended
UNAUDITED CONDENSED INTERIM CONSOLIDATED FINANCIAL STATEMENTS For the Three Month Periods Ended March 31, 2018 and March 31, 2017 (in thousands of Canadian dollars) Unaudited Condensed Interim Consolidated Financial Statements For the three month periods ended March 31, 2018
Read more →CRONCronos Group Inc. to Hold Conference Call on First Quarter 2018 Financial Results TORONTO
Cronos Group Inc. to Hold Conference Call on First Quarter 2018 Financial Results TORONTO, May 9, 2018 /CNW/ - Cronos Group Inc. (NASDAQ, TSX-V: CRON) ("Cronos Group" or the "Company") will release its financial results for the first quarter ended March 31, 2018 before the ma
Read more →CRONBY-LAW NO. 5 (repealing and replacing By-Law No. 3 and By-Law No. 4) A by-law relating generally to the conduct of the affairs of CRONOS GROUP INC. (hereinafter called the Corporation ) BE IT ENACTED and it is hereby ena
(repealing and replacing By-Law No. 3 and By-Law A by-law relating generally to the conduct of the affairs of (hereinafter called the Corporation ) BE IT ENACTED and it is hereby enacted as a by-law of the Corporation as follows: In this by-law of the Corporation, unless the
Read more →CRONCronos Group Inc. Announces Fourth Quarter and Fiscal Year 2017 Results Q4 2017 sales of $1.6 million, up 274% year over year FY 2017 sales of $4.1 million, up 636% year over year Peace Naturals greenhouse construction c
Cronos Group Inc. Announces Fourth Quarter and Fiscal Q4 2017 sales of $1.6 million, up FY 2017 sales of $4.1 million, up Peace Naturals greenhouse construction complete and facility operational TORONTO, April 30, 2018 /CNW/ - Cronos Group Inc. (NASDAQ, TSX-V: CRON) ("Crono
Read more →CRONCronos Group Inc. to Hold Conference Call on Fourth Quarter and Fiscal Year 2017 Financial Results TORONTO
Cronos Group Inc. to Hold Conference Call on Fourth Quarter and Fiscal Year 2017 Financial Results TORONTO, April 27, 2018 /CNW/ - Cronos Group Inc. (NASDAQ, TSX-V: CRON) ("Cronos Group" or the "Company") will release its financial results for the fourth quarter and fiscal ye
Read more →CRONCronos Group Announces Closing of Previously Announced $100 Million Bought Deal TORONTO
Cronos Group Announces Closing of Previously Announced $100 Million Bought Deal TORONTO, April 6, 2018 - Cronos Group Inc. (NASDAQ, TSX-V: CRON) ("Cronos Group" or the "Company") is pleased to announce that it has closed its previously announced bought deal public offering. A
Read more →CRONCronos Group Inc. Announces $100 Million Bought Deal TORONTO
Cronos Group Inc. Announces $100 Million Bought Deal TORONTO, March 21, 2018 /CNW/ - Cronos Group Inc. (NASDAQ, TSX-V: CRON) ("Cronos Group" or the "Company") is pleased to announce that it has entered into an agreement with a syndicate of underwriters led by GMP Securities L.
Read more →CRONC O R R E C T I O N from Source -- Cronos Group Inc./ In the news release, Cronos Group Inc. Announces $100 Million Bought Deal, issued 21-Mar-2018 by Cronos Group Inc. over Cision, we are advised by the company that the
/C O R R E C T I O N from Source -- Cronos Group Inc./ In the news release, Cronos Group Inc. Announces $100 Million Bought Deal, issued 21-Mar-2018 by Cronos Group Inc. over Cision, we are advised by the company that the syndicate of underwriters listed in the first paragraph
Read more →CRONCannabis Giants Join Forces in Cross Border Venture TORONTO
Cannabis Giants Join Forces in Cross Border Venture TORONTO, March 19, 2018 /CNW/ - Cronos Group Inc. (Nasdaq: CRON) (TSX-V: CRON) ("Cronos" or the "Company") - With Canada on track to legalize adult use of cannabis, two of the world's largest cannabis companies announced a fi
Read more →CRONCronos Group Grants Stock Options
TORONTO, ONTARIO--(Marketwired - Nov. 21, 2016) - NOT FOR DISSEMINATION IN THE UNITED STATES OR THROUGH UNITED STATES NEWSWIRE SERVICES PharmaCan Capital Corp. doing business as Cronos Group ("Cronos Group" or the "Company") (TSX VENTURE:MJN) announces it has granted options to
Read more →Competitive Position
How CRON ranks across every disease it competes inCompetitive Position is a premium feature
See how CRON ranks against every competitor across each disease it develops in: phase, best drug, trials and likelihood of approval.
Start free trial